Balint, L.; Socaciu, C.; Socaciu, A.I.; Vlad, A.; Gadalean, F.; Bob, F.; Milas, O.; Cretu, O.M.; Suteanu-Simulescu, A.; Glavan, M.;
et al. Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. Biomolecules 2023, 13, 1086.
https://doi.org/10.3390/biom13071086
AMA Style
Balint L, Socaciu C, Socaciu AI, Vlad A, Gadalean F, Bob F, Milas O, Cretu OM, Suteanu-Simulescu A, Glavan M,
et al. Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. Biomolecules. 2023; 13(7):1086.
https://doi.org/10.3390/biom13071086
Chicago/Turabian Style
Balint, Lavinia, Carmen Socaciu, Andreea Iulia Socaciu, Adrian Vlad, Florica Gadalean, Flaviu Bob, Oana Milas, Octavian Marius Cretu, Anca Suteanu-Simulescu, Mihaela Glavan,
and et al. 2023. "Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients" Biomolecules 13, no. 7: 1086.
https://doi.org/10.3390/biom13071086
APA Style
Balint, L., Socaciu, C., Socaciu, A. I., Vlad, A., Gadalean, F., Bob, F., Milas, O., Cretu, O. M., Suteanu-Simulescu, A., Glavan, M., Ienciu, S., Mogos, M., Jianu, D. C., & Petrica, L.
(2023). Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. Biomolecules, 13(7), 1086.
https://doi.org/10.3390/biom13071086
